Lundbeck Promotes Tarek Samad to Head of R&D as Johan Luthman Retires
Event summary
- Tarek Samad appointed EVP, Head of R&D at Lundbeck effective September 1, 2026.
- Johan Luthman retires after seven years leading R&D, overseeing pipeline transformation.
- Samad previously served as Senior VP, Global Head of Research and Corporate Patents since 2021.
- Transition period begins July 2026 with Luthman remaining until year-end for continuity.
The big picture
Lundbeck's internal promotion reflects its commitment to continuity in neuroscience R&D leadership. The transition comes as the company positions itself as a focused innovator in brain health, with Samad's background in strategic partnerships potentially shaping future collaboration models. His appointment follows Luthman's successful restructuring of R&D capabilities and expansion into new biological research areas.
What we're watching
- Pipeline Momentum
- Whether Samad can sustain the first-in-class innovation focus established under Luthman.
- Strategic Partnerships
- How Samad will leverage his external collaborations to accelerate Lundbeck's R&D progress.
- Leadership Continuity
- The effectiveness of the transition period in maintaining scientific and strategic priorities.
Related topics